Markus Loeffler
Impact in
- Pathology and Forensic Medicine top 0.02%
- Lymphoma Diagnosis and Treatment
- Genetic factors in colorectal cancer
- Genetics top 0.2%
- Genetic Associations and Epidemiology
- Glioma Diagnosis and Treatment
Papers in
-
- Lymphoma Diagnosis and Treatment 107
- Genetic factors in colorectal cancer 27
- Hematology 65
- Hematopoietic Stem Cell Transplantation 46
- Erythropoietin and Anemia Treatment 22
- Co-authors
- Christopher S. Potten (23 shared papers)Michael G. Pfreundschuh (52 shared papers)Norbert Schmitz (37 shared papers)Ingo Roeder (18 shared papers)Christoph Engel (65 shared papers)Marita Ziepert (28 shared papers)Dirk Hasenclever (20 shared papers)Markus Scholz (51 shared papers)
- Journals
- Blood (44 papers)Annals of Oncology (25 papers)Nature Communications (25 papers)Cell Proliferation (22 papers)PLoS ONE (18 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Markus Loeffler
490 papers receiving 41.3k citations
Markus Loeffler's Hit Papers
Peers
Comparison fields: 5 of 201
- Pathology and Forensic Medicine 12.3k
- Genetics 3.1k
- Modeling and Simulation 1.1k
- Genetics 5.4k
- Hematology 1.9k
Countries citing papers authored by Markus Loeffler
This map shows the geographic impact of Markus Loeffler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Loeffler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Loeffler more than expected).
Fields of papers citing papers by Markus Loeffler
This network shows the impact of papers produced by Markus Loeffler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Loeffler. The network helps show where Markus Loeffler may publish in the future.
Co-authors
The 25 scholars most cited alongside Markus Loeffler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 498 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Intensive Insulin Therapy and Pentastarch Resuscitation in Severe Sepsis Hit paper breakdown → | 2008 | 2177 |
| 2 | CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group Hit paper breakdown → | 2006 | 1710 |
| 3 | Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression Hit paper breakdown → | 2021 | 1527 |
| 4 | Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt Hit paper breakdown → | 1990 | 1506 |
| 5 | Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes Hit paper breakdown → | 2018 | 1462 |
| 6 | Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60) Hit paper breakdown → | 2008 | 926 |
| 7 | A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling Hit paper breakdown → | 2006 | 788 |
| 8 | Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas Hit paper breakdown → | 2010 | 693 |
| 9 | CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group Hit paper breakdown → | 2011 | 654 |
| 10 | Standard and Increased-Dose BEACOPP Chemotherapy Compared with COPP-ABVD for Advanced Hodgkin's Disease Hit paper breakdown → | 2003 | 636 |
| 11 | A catalog of genetic loci associated with kidney function from analyses of a million individuals Hit paper breakdown → | 2019 | 617 |
| 12 | Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes Hit paper breakdown → | 2018 | 615 |
| 13 | The power of genetic diversity in genome-wide association studies of lipids Hit paper breakdown → | 2021 | 601 |
| 14 | Molecular Predictors of Progression-Free and Overall Survival in Patients With Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma Network Hit paper breakdown → | 2009 | 526 |
| 15 | Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database Hit paper breakdown → | 2019 | 488 |
| 16 | A saturated map of common genetic variants associated with human height Hit paper breakdown → | 2022 | 485 |
| 17 | Standard International Prognostic Index Remains a Valid Predictor of Outcome for Patients With Aggressive CD20 + B-Cell Lymphoma in the Rituximab Era Hit paper breakdown → | 2010 | 479 |
| 18 | 2007 | 478 | |
| 19 | Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group Hit paper breakdown → | 2010 | 451 |
| 20 | MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma Hit paper breakdown → | 2013 | 449 |
About Markus Loeffler
Markus Loeffler is a scholar working on Pathology and Forensic Medicine, Hematology, Genetics, Genetics and Oncology, having authored 498 papers that have together received 42.5k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (107 papers), Genetic Associations and Epidemiology (49 papers), Hematopoietic Stem Cell Transplantation (46 papers), Genetic factors in colorectal cancer (27 papers), Erythropoietin and Anemia Treatment (22 papers), Glioma Diagnosis and Treatment (20 papers), Cancer Cells and Metastasis (18 papers) and Mathematical Biology Tumor Growth (16 papers). The work is most often cited by research in Pathology and Forensic Medicine (12.3k citations), Genetics (3.1k citations), Modeling and Simulation (1.1k citations), Genetics (5.4k citations) and Hematology (1.9k citations). Markus Loeffler has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Christopher S. Potten, Michael G. Pfreundschuh, Norbert Schmitz, Ingo Roeder, Christoph Engel, Marita Ziepert, Dirk Hasenclever, Markus Scholz, Lorenz H. P. Trümper and Volker Diehl. Their work appears in journals such as Blood, Annals of Oncology, Nature Communications, Cell Proliferation and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.